Nanotechnology and Nanomedicine: A Promising Avenue for Lung Cancer Diagnosis and Therapy

Lung cancer is a leading cause of cancer-related death worldwide, with very poor overall five-year survival rate. The intrinsic limitations associated the conventional diagnosis and therapeutic strategies used for lung have motivated development nanotechnology nanomedicine approaches, in order to improve early rate develop more effective safer options cancer. Cancer nanomedicines aim individualize drug delivery, diagnosis, therapy by tailoring them each patient’s unique physiology pathological features—on both genomic proteomic levels—and attracted widespread attention this field. Despite successful application techniques research, clinical translation approaches remains challenging due limited understanding interactions that occur between biology, challenges posed toxicology, pharmacology, immunology, large-scale manufacturing nanoparticles. In review, we highlight progress opportunities use treatment discuss prospects field, together translation.